Daiwa Securities Group Inc. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$12,000
+71.4%
570.0%0.00%
Q4 2020$7,000
-58.8%
57
-66.5%
0.00%
Q3 2020$17,000
+13.3%
170
+2.4%
0.00%
Q2 2020$15,0000.0%1660.0%0.00%
Q1 2020$15,000
-11.8%
1660.0%0.00%
Q4 2019$17,000
-22.7%
166
-11.7%
0.00%
Q3 2019$22,000
-31.2%
188
+2.2%
0.00%
Q2 2019$32,000
+3.2%
1840.0%0.00%
Q1 2019$31,000
+63.2%
184
-3.7%
0.00%
Q4 2018$19,000
-17.4%
191
+45.8%
0.00%
Q3 2018$23,000
+27.8%
1310.0%0.00%
Q2 2018$18,000
+20.0%
1310.0%0.00%
Q1 2018$15,0001310.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders